KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Equity Average (2016 - 2025)

Historic Equity Average for Exact Sciences (EXAS) over the last 16 years, with Q4 2025 value amounting to $2.5 billion.

  • Exact Sciences' Equity Average fell 1265.49% to $2.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 billion, marking a year-over-year decrease of 1265.49%. This contributed to the annual value of $2.4 billion for FY2025, which is 1341.59% down from last year.
  • According to the latest figures from Q4 2025, Exact Sciences' Equity Average is $2.5 billion, which was down 1265.49% from $2.5 billion recorded in Q3 2025.
  • Over the past 5 years, Exact Sciences' Equity Average peaked at $3.6 billion during Q2 2021, and registered a low of $2.4 billion during Q1 2025.
  • Moreover, its 5-year median value for Equity Average was $3.1 billion (2023), whereas its average is $3.0 billion.
  • In the last 5 years, Exact Sciences' Equity Average skyrocketed by 4969.92% in 2021 and then crashed by 2355.5% in 2025.
  • Over the past 5 years, Exact Sciences' Equity Average (Quarter) stood at $3.4 billion in 2021, then dropped by 10.13% to $3.1 billion in 2022, then rose by 1.87% to $3.1 billion in 2023, then dropped by 10.43% to $2.8 billion in 2024, then decreased by 12.65% to $2.5 billion in 2025.
  • Its last three reported values are $2.5 billion in Q4 2025, $2.5 billion for Q3 2025, and $2.4 billion during Q2 2025.